John A. Golden
President chez John A. Golden Associates, Inc.
Profil
John A.
Golden is currently the Director at T3D Therapeutics, Inc. and the President at Mr. Golden Associates, Inc. He previously worked as the Chairman at Colgate University and as a Director at Abercrombie & Fitch Co. He has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Colgate University.
Postes actifs de John A. Golden
| Sociétés | Poste | Début |
|---|---|---|
| John A. Golden Associates, Inc. | President | - |
T3D Therapeutics, Inc.
 T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Directeur/Membre du Conseil | - |
Anciens postes connus de John A. Golden
| Sociétés | Poste | Fin |
|---|---|---|
| Colgate University | Président | - |
| ABERCROMBIE & FITCH CO. | Directeur/Membre du Conseil | - |
Formation de John A. Golden
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Colgate University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABERCROMBIE & FITCH CO. | Retail Trade |
| Entreprise privées | 2 |
|---|---|
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Health Technology |
| John A. Golden Associates, Inc. |
